FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

被引：196

作者：

Urwin, Hazel ^{[1
]}

Josephs, Keith A. ^{[5
]}

Rohrer, Jonathan D. ^{[2
]}

Mackenzie, Ian R. ^{[7
]}

Neumann, Manuela ^{[8
]}

Authier, Astrid ^{[1
]}

Seelaar, Harro ^{[9
]}

Van Swieten, John C. ^{[9
]}

Brown, Jeremy M. ^{[10
]}

Johannsen, Peter ^{[11
]}

Nielsen, Jorgen E. ^{[11
,12
]}

Holm, Ida E. ^{[13
]}

Dickson, Dennis W. ^{[14
]}

Rademakers, Rosa ^{[14
]}

Graff-Radford, Neill R. ^{[14
]}

Parisi, Joseph E. ^{[6
]}

Petersen, Ronald C. ^{[5
]}

Hatanpaa, Kimmo J. ^{[15
]}

White, Charles L., III ^{[15
]}

Weiner, Myron F. ^{[16
,17
]}

Geser, Felix ^{[18
]}

Van Deerlin, Vivianna M. ^{[18
]}

Trojanowski, John Q. ^{[18
]}

Miller, Bruce L. ^{[19
]}

Seeley, William W. ^{[19
]}

van der Zee, Julie ^{[20
,21
]}

Kumar-Singh, Samir ^{[20
,21
]}

Engelborghs, Sebastiaan ^{[21
,22
]}

De Deyn, Peter P. ^{[21
,22
]}

Van Broeckhoven, Christine ^{[20
,21
]}

Bigio, Eileen H. ^{[23
]}

Deng, Han-Xiang ^{[24
]}

Halliday, Glenda M. ^{[25
]}

Kril, Jillian J. ^{[26
]}

Munoz, David G. ^{[27
]}

Mann, David M. ^{[28
]}

Pickering-Brown, Stuart M. ^{[29
]}

Doodeman, Valerie ^{[30
]}

Adamson, Gary ^{[1
]}

Ghazi-Noori, Shabnam ^{[1
]}

Fisher, Elizabeth M. C. ^{[3
]}

Holton, Janice L. ^{[4
]}

Revesz, Tamas ^{[4
]}

Rossor, Martin N. ^{[2
]}

Collinge, John ^{[1
,3
]}

Mead, Simon ^{[1
]}

Isaacs, Adrian M. ^{[1
]}

机构：

[1] UCL Inst Neurol, MRC Prion Unit, London WC1N 3BG, England

[2] UCL Inst Neurol, Dementia Res Ctr, London WC1N 3BG, England

[3] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England

[4] UCL Inst Neurol, Dept Neuropathol, London WC1N 3BG, England

[5] Mayo Clin, Dept Neurol, Rochester, MN USA

[6] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA

[7] Univ British Columbia, Dept Pathol & Lab Med, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada

[8] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland

[9] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands

[10] Addenbrookes Hosp, Dept Neurol, Cambridge, England

[11] Copenhagen Univ Hosp, Memory Disorders Res Unit, Dept Neurol, Copenhagen, Denmark

[12] Univ Copenhagen, Dept Cellular & Mol Med, Neurogenet Sect, Panum Inst, Copenhagen, Denmark

[13] Aarhus Univ Hosp, Dept Pathol, Randers Hosp, Randers & Lab Expt Neuropathol,Danish Neurosci Ct, DK-8000 Aarhus, Denmark

[14] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA

[15] Univ Texas SW Med Sch, Dept Pathol, Dallas, TX USA

[16] Univ Texas SW Med Sch, Dept Psychiat, Dallas, TX USA

[17] Univ Texas SW Med Sch, Dept Neurol, Dallas, TX USA

[18] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA

[19] UCSF, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA

[20] VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, Antwerp, Belgium

[21] Univ Antwerp, Inst Born Bunge, B-2020 Antwerp, Belgium

[22] ZNA Middelheim, Dept Neurol, Memory Clin, Antwerp, Belgium

[23] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA

[24] Northwestern Univ, Dept Neurol & Clin Neurosci, Feinberg Sch Med, Chicago, IL 60611 USA

[25] Univ New S Wales, Prince Wales Med Res Inst, Sydney, NSW, Australia

[26] Univ Sydney, Disciplines Med & Pathol, Sydney, NSW 2006, Australia

[27] Univ Toronto, St Michaels Hosp, Dept Pathol, Toronto, ON M5B 1W8, Canada

[28] Univ Manchester, Clin Neurosci Res Grp, Sch Translat Med, Greater Manchester Neurosci Ctr, Salford, Lancs, England

[29] Univ Manchester, Clin Neurosci Res Grp, Fac Human & Med Sci, Manchester M13 9PT, Lancs, England

[30] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands

来源：

ACTA NEUROPATHOLOGICA | 2010年 / 120卷 / 01期

基金：

美国国家卫生研究院; 英国医学研究理事会;

关键词：

FTLD; FUS; FTLD-UPS; Frontotemporal; FTD; MOTOR-NEURON DISEASE; FILAMENT INCLUSION DISEASE; PICKS-DISEASE; GENE-MUTATIONS; BODY DISEASE; FTLD-U; DEMENTIA; PROGRANULIN; TDP-43; HETEROGENEITY;

D O I：

10.1007/s00401-010-0698-6

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Through an international consortium, we have collected 37 tau- and TAR DNA-binding protein 43 (TDP-43)-negative frontotemporal lobar degeneration (FTLD) cases, and present here the first comprehensive analysis of these cases in terms of neuropathology, genetics, demographics and clinical data. 92% (34/37) had fused in sarcoma (FUS) protein pathology, indicating that FTLD-FUS is an important FTLD subtype. This FTLD-FUS collection specifically focussed on aFTLD-U cases, one of three recently defined subtypes of FTLD-FUS. The aFTLD-U subtype of FTLD-FUS is characterised clinically by behavioural variant frontotemporal dementia (bvFTD) and has a particularly young age of onset with a mean of 41 years. Further, this subtype had a high prevalence of psychotic symptoms (36% of cases) and low prevalence of motor symptoms (3% of cases). We did not find FUS mutations in any aFTLD-U case. To date, the only subtype of cases reported to have ubiquitin-positive but tau-, TDP-43- and FUS-negative pathology, termed FTLD-UPS, is the result of charged multivesicular body protein 2B gene (CHMP2B) mutation. We identified three FTLD-UPS cases, which are negative for CHMP2B mutation, suggesting that the full complement of FTLD pathologies is yet to be elucidated.

引用

页码：33 / 41

页数：9

共 50 条

[21] TDP-43 Variants of Frontotemporal Lobar Degeneration
Bigio, Eileen H.
JOURNAL OF MOLECULAR NEUROSCIENCE, 2011, 45 (03) : 390 - 401
[22] Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns
Armstrong, Richard A.
FOLIA NEUROPATHOLOGICA, 2017, 55 (03) : 185 - 192
[23] In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology
Martina Bocchetta
Maria del Mar Iglesias Espinosa
Tammaryn Lashley
Jason D. Warren
Jonathan D. Rohrer
Alzheimer's Research & Therapy, 12
[24] Biomarker for Frontotemporal Lobar Degeneration (FTLD) with TDP-43 Pathology: the Circulating Lymphocytes
Pellerino, Alessia
Lomartire, A.
Naldi, A.
Buccinna, B.
Maffeo, E.
Ramondetti, C.
Lupino, E.
Rinaudo, M. T.
Piccinini, M.
Rainero, I
De Marco, G.
Giordana, M. T.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 99 - 100
[25] White matter pathology in sporadic frontotemporal lobar degeneration with TDP-43 proteinopathy
Armstrong, Richard A.
CLINICAL NEUROPATHOLOGY, 2017, 36 (02) : 66 - 72
[26] Amygdala TDP-43 Pathology in Frontotemporal Lobar Degeneration and Motor Neuron Disease
Takeda, Takahiro
Seilhean, Danielle
Le Ber, Isabelle
Millecamps, Stephanie
Sazdovitch, Veronique
Kitagawa, Kazuo
Uchihara, Toshiki
Duyckaerts, Charles
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (09): : 800 - 812
[27] In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology
Bocchetta, Martina
Iglesias Espinosa, Maria del Mar
Lashley, Tammaryn
Warren, Jason D.
Rohrer, Jonathan D.
ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
[28] Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers
Cousins, Katheryn A. Q.
Shaw, Leslie M.
Chen-Plotkin, Alice
Wolk, David A.
Van Deerlin, Vivianna M.
Lee, Edward B.
McMillan, Corey T.
Grossman, Murray
Irwin, David J.
JAMA NEUROLOGY, 2022, 79 (11) : 1155 - 1164
[29] TDP-43 frontotemporal lobar degeneration and autoimmune disease
Miller, Zachary A.
Rankin, Katherine P.
Graff-Radford, Neill R.
Takada, Leonel T.
Sturm, Virginia E.
Cleveland, Clare M.
Criswell, Lindsey A.
Jaeger, Philipp A.
Stan, Trisha
Heggeli, Kristin A.
Hsu, Sandy Chan
Karydas, Anna
Khan, Baber K.
Grinberg, Lea T.
Gorno-Tempini, Maria Luisa
Boxer, Adam L.
Rosen, Howard J.
Kramer, Joel H.
Coppola, Giovanni
Geschwind, Daniel H.
Rademakers, Rosa
Seeley, William W.
Wyss-Coray, Tony
Miller, Bruce L.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (09): : 956 - 962
[30] TDP-43 gene analysis in frontotemporal lobar degeneration
Rollinson, Sara
Snowden, Julie S.
Neary, David
Morrison, Karen E.
Mann, David M. A.
Pickering-Brown, Stuart M.
NEUROSCIENCE LETTERS, 2007, 419 (01) : 1 - 4

← 1 2 3 4 5 →